1. Home
  2. /
  3. Venture Capital
  4. /
  5. BIOPHTA raises 6.5 million...

News / Venture Capital

BIOPHTA raises 6.5 million Euros Seed Funding to transition its New Standard of Care for Eye Diseases to the Clinical stage.

3 June 2024
BIOPHTA, a preclinical biotech company developing a game-changing technology for the treatment of eye diseases, has just closed a € 6.5 million Seed round to bring its patented technology to clinical development.

Download

Press Release
Download

Related News

arrow-up-right
Deepull-logo
arrow-up-right